Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
Experimental drug 'successfully treated doctor who contracted Ebola'
A drug currently being tested against vascular leakage successfully treated a doctor who contracted Ebola in Sierra Leone, according to a new report published in The Lancet.
New hope for rare disease drug development - Charcot-Marie-Tooth type 1A disease (CMT1A)
Using combinations of well-known approved drugs has for the first time been shown to be potentially safe in treating a rare disease, according to the results of a clinical trial published in the...
53 Ebola-blocking drugs identified among existing medications
Using high-speed screening technology, researchers have identified 53 drugs - including some antihistamines and antidepressants - that may prevent Ebola from entering human cells.
Herceptin for HER2-positive breast cancer improves long-term survival
A new study shows that when added to chemotherapy, trastuzumab - commonly known as Herceptin - significantly improves long-term survival of HER2-positive breast cancer patients.
VR475 shown significant benefit in a Phase IIb/III trial for severe asthma
Vectura Group plc has announced the publication in the European Respiratory Journal (ERJ) of a clinical study demonstrating positive results from its Phase IIb/III (Acti-AICS-001) clinical trial...
Tamoxifen has reduced breast cancer rates 'by a third'
A well-established and effective treatment for breast cancer, tamoxifen has now been shown to have long-term preventive benefits for women at high risk.
Primary data from Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy announced
UCB has announced the primary efficacy and safety data from the latest Phase 3 study evaluating brivaracetam (fixed doses of 100 and 200 mg/day with no up-titration) as adjunctive treatment in...
Follow-up data from idelalisib (Zydelig) registrational studies in patients with chronic lymphocytic leukaemia and follicular lympho
Gilead Sciences, Inc. has announced long-term follow-up results from the registration studies further describing the duration of response, progression-free survival (PFS) and the safety profile for...
Positive top-line results from Phase 3 trial of baricitinib in moderate to severe rheumatoid arthritis
Eli Lilly and Company and Incyte Corporation have announced that the Phase 3 RA-BEACON study of the investigational medicine baricitinib met its primary endpoint of improved ACR20 response compared...
Phase III GXR study shows improvement in core symptoms of ADHD
Results published in European Neuropsychopharmacology demonstrate the efficacy of the Attention-Deficit/Hyperactivity Disorder (ADHD) medication, guanfacine hydrochloride extended release (GXR).
Treatment for relapsed multiple myeloma patients guided by FoundationOne® Heme results in promising clinical activity
Foundation Medicine, Inc. has announced new data demonstrating that its comprehensive genomic profile, FoundationOne® Heme, identified genomic alterations in patients with heavily pre-treated...
Parkinson's vaccine tested on first patients
A novel Parkinson's vaccine will now be tested in a clinical Phase I trial in Austria by an EU-funded consortium.
Hodgkin lymphoma: Phase 3 AETHERA clinical trial data reported
Takeda UK Ltd has reported data demonstrating that Hodgkin lymphoma (HL) patients at risk of relapse following an autologous stem cell transplant (ASCT) who received ADCETRIS (brentuximab vedotin)...
Most exaggeration in health news is already present in academic press releases
Most exaggeration in health related science news is already present in academic press releases, finds a study published in The BMJ this week.
Asthma data shows no additional clinical efficacy benefits for ICS-treatments with a small particle size
GSK has presented data at the British Thoracic Society (BTS) meeting from a systematic analysis of 25 randomised control studies (RCTs), including a meta-analysis of three key efficacy outcomes...
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2014
Content Management / Website Design by Tresware